Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer
Status:
Unknown status
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
A prospective evaluation of neoadjuvant FOLFIRINOX regimen in patients with non-metastatic
pancreas cancer (Baylor University Medical Center and Texas Oncology Experience)